A B S T R A C T The effectiveness of xenogeneic embryonic tissue in the treatment of experimental diabetes has been investigated in rats. The splenic lobes (80) of 15-to 18d-old chick embryos, composed almost exclusively of endocrine tissue, were implanted directly into the hepatic parenchyma of the rat recipient. The biochemical and metabolic changes in the recipients suggest that embryonic transplants of 15-d-old chick pancreases were able to significantly improve, for a prolonged period of time (18 mo), the diabetic state of nonimmunosuppressed rats. None of the recipients of 18-d-old embryos splenic lobes exhibited a long-term improvement ofthe diabetic state after transplantation. The complete destruction of the pancreatic B cells of the recipients was asssessed by: (a) immunocytochemical investigations of the recipient's pancreas, (b) measurement of insulin in the liver and pancreas of the recipients and (c) in situ vascular perfusion of their pancreas submitted to high glucose challenge. The results suggest that pancreatic tissue of the 15-d-old embryos is immunologically immature lacking one or several lymphocyte subsets implicated in the afferent loop of "non-self" recognition.
INTRODUCTION
At present, studies on the treatment of insulin-deficient diabetes mellitus have focused both on insulin replacement by islet transplantation and on glucagon suppression (1) . Encouraging results have been obtained by transplanting isolated pancreatic islets into the peritoneal cavity with partial alleviation of the diabetic state (2, 3) , by injecting islets into the portal vein followed by a complete reversal of diabetes (4) , or by implanting them directly into the liver (5) . Isogeneic transplanted islets have remained functioning for >15 mo (5) .
In contrast, islet allografts have not reversed hyperglycemia and long-term survival of the allografts has been difficult to achieve in rats with experimental diabetes. Allogeneic islets transplanted across the major histocompatibility locus of the rat, AgB, have all been rejected rapidly, functioning for only 2-6 d (6, 7) and immunosuppression by agents such as azathioprine and methyl prednisolone have not been very helpful (8; 9) . Pretreatment of the recipient with donor liver extract and pertussis followed by a short course of antilymphocyte serum treatment has resulted in a much better overall survival of functioning islet allotransplants and the mean survival time +SEM was 37.7±18.9 d (10) . In a previous study, in vitro culture before transplantation has been associated with prolonged survival of allogeneic islets across strongly histoincompatible barriers (11) .
Apart from immunological incompatibility, other technical problems arise. Current techniques to isolate islets from the adult pancreas (collagenase digestion followed by either density gradient separation or handpicking of islets under a dissecting microscope) are laborious and lose a considerable number of islets. In addition, even in rodents, the techniques are not fully efficient because several adult donor rats are required to provide sufficient islet tissue for the suppression of the diabetic state of only one recipient. Difficulties increase even more when one attempts to isolate islets from the compact adult human pancreas and the yield is variable and unpredictable (12) . Thus, the problems of isolating large numbers of viable islets as well as the requirement for a more effective immunosuppressive therapy still remain unsolved.
Theoretically, fetal islets might be preferable for transplantation because they could possibly have several advantages over adult islets: (a) in some situations fetal tissue is clearly less antigenic than the corresponding adult tissue (13, 14) ; (b) fetal islets might have more potential for growth after transplantation (15, 16) ; and (c) a period of ischemia might be better tolerated by fetal than adult islet tissue.
In fact blood sugar levels were completely or partially controlled up to 165 d in diabetic syngeneic recipient rats using one to three fetal rat pancreases (17, 18) . However, with homografts of fetal and(or) neonatal rat pancreas, a transitory reversal ofdiabetes was generally observed but symptoms returned in 2 or 3 wk with the rejection of the transplants (19) . Only 20% of the recipients of fetal homografts were considered as successful without evidence of rejection in the study reported by Gonet and Renold (20) . In a more recent study, 7 out of 10 allogeneic transplants were surviving 2 mo after implantation in nonimmunosuppressed histoincompatible recipients (21) .
There has been little experimental work on pancreatic islet cell xenografts but it has been reported that islet allografts and xenografts have similar morphologic and functional survival in non immunosuppressed diabetic rats and mice (22) (23) (24) . Because human diabetics are treated with xenogeneic insulin, and because the chick embryonic pancreas provides a relatively pure source ofendocrine tissue, the effectiveness of this xenogeneic embryonic tissue in experimental diabetes was investigated in this study. The splenic lobes of chick embryos were implanted directly into the hepatic parenchyma of the rat recipient because the liver may represent an immunologically privileged site (25) (26) (27) Metabolic and chemical analyses. The insulin content of the chicken pancreases was determined according to the tech-FIGURE 1 Splenic (S) and ventral (V) lobes of the pancreas in the chick embryo.
nique previously described (28) . Acid-alcoholic extracts were dissolved in 0.04 M phosphate buffer, pH 7.4, with 0.002% merthiolate, 0.2% human albumin, and 0.6% saline. After several trials, one guinea pig antiserum against pig insulin was selected because of its high affinity for chick embryo insulin. In this study, chicken insulin was used as a standard.
The progress of the animals was followed by determination of: (a) and( maintained in the recipients several months after administration of Streptozotocin. Similar experiments were also performed in 7 normal rats and in 10 nongrafted diabetic animals. The in situ vascular perfusion of the rat pancreas was set up by modifying previously described procedures both in dogs and rats (30, 31) . Through a midline vertical laparotomy the peritoneum overlying the aorta was stripped off to expose the origins of the celiac and superior mesenteric arteries. Both renal and adrenal vessels were ligated. The aorta was dissected below the renal arteries and a fine polythene heparinized catheter was introduced into the aorta. The top of the catheter was placed opposite the origin of the superior mesenteric artery. The portal vein was isolated after its junction with the superior duodenopancreatic vein, and cannulated towards its mesenteric end. Its hepatic end was ligated so that the panicreatic and mesenteric effluent could be collected. The inferior vena cava was dissected below the renal vessels, and a metallic cannula filled with heparinized physiological buffer solution was adjusted to lie just caudal to them. It was connected to a calibrated nonperistaltic pump and undiluted homologous heparinized fresh blood was injected so as to maintain a constant arterial pressure of =90-100 mm Hg. The blood collected from the portal vein was not recirculated.
A glucose load was given by additional infusion of glucose (25 g/100 ml) into the inferior vena cava catheter at a constant rate of 0.2 ml/min over 10 min. Blood samples were drawn from the aortic and portal catheters and from the blood reservoir every 2-5 min. Glucose and insulin assays were performed on each sample. The output of insulin solely from the recipient's pancreas was determined by the following formula: portal insulin concentration minus aortic insulin concentration in microunits per milliliter times portal venous output in milliliters per minute. Extrapancreatic insulin output from nonpancreatic B cells can sometimes be detected when, despite complete diversion of the normal pancreatic endocrine secretion by way of the portal catheter, the aortic insulin concentration is significantly higher than that of the blood reservoir.
RESULTS
Diabetic nontreated animals (group I, n = 31). The following data were obtained by pooling the results from the diabetic animals surviving >10 d after the injection of Streptozotocin. The mean survival time of these animals was 27.26+2.94 d after induction of diabetes. The weight of these animals decreased progressively and by the 21st d it was 76.3+±3.4% oftheir weight at induction of diabetes (Table I ). The mean fasting glycemia was 2.91+0.13 glliter. Nonfasting glycemia was higher than 5.87+0.17 g/liter. The output of urine averaged 92.2 +2.6 ml/24 h and the mean urinary glucose losses was 83.7+6.08 g/liter or =7-9 g/d. Immunoreactive circulating levels of insulin were 2.57+0.32 and 2.58 +0.55 uU/ml in the fasting and nonfasting states, respectively.
Normal animals (group II, n = 28). Rats of the same initial weight (150-200 g) were studied for more Table I . There was no significant difference between controls (group II) and transplanted rats, but in the latter the weight gain was significantly higher than in non-transplanted diabetic animals (group I), or in those grafted with endocrine tissue from 18-d-old embryos (group III). The survival time of the transplanted animals was >180 d after the induction of diabetes.
Xenotransplantation of Embryonic Endocrine Pancreas in the Rat
Nonfasting serum glucose levels fluctuated as shown in Fig. 3 . During the 2 wk after transplantation they were significantly different from diabetic levels, and from those of normal control animals (P < 0.05). However, the fasting serum sugar levels progressively fell and were not different from that of control animals (Group II) by the 3rd posttransplant wk. Nonfasting glycemia was not significantly different from control animals even at the 150th posttransplant d.
Urine volumes were significantly reduced after transplantation but remained significantly larger than those of control animals (Table II) for a prolonged period of time (18 mo) an experimental diabetic state in non immunosuppressed rats. Because these results were surprising, it was necessary to demonstrate that a spontaneous recovery from the diabetic state had not occurred. There are conflicting reports of spontaneous recovery from Streptozotocin diabetes. In mice, streptozotocin diabetes shows no tendency to remit (32) , but damage to islet B cells in rats that receive lower doses of Streptozotocin is apparently reversible (33, 34) . It is well known that in certain species and in man hyperglycemia seems to be a stimulus for B-cell proliferation. Arison et al. (33) reported a slight regenerative activity in mild streptozotocin diabetic rats but Magnall et al. (35) demonstrated that pancreatic insulin concentration remains similar to that of diabetic controls despite the presence of granulated B cells in the host pancreas. Because histological or immunocytochemical investigationis are not a quantitative assessment of pancreatic destruction, the functional response of host pancreas, its insulin content, and the liver insulin content have been investigated before and after transplantation. Although the insulin content of the liver, determined both at the 15th and 60th posttransplant d was significantly different of that from control or diabetic nongrafted animals, the values obtained were unexpectedly very low, compared with the amount of endocrine tissue transplanted. The presence of a pancreatic graft cannot be considered responsible for a recovery of the recipient's pancreas, because the insulin content of the caudal pancreas of grafted animals was not modified, compared with diabetic nontreated animals. Moreover, the presence of immunoassayable insulin material within the caudal pancreas of diabetic rats, transplanted or not, was not associated with the demonstration of immunoreactive insulin cells. Hyperplasia of glucagon cells was visualized. The functional response of the recipient's pancreas tested by perfusion experiments clearly demonstrates the absence of host pancreas responise to high glucose and suggests the existence in the host of a nonpancreatic source of circulating insulin.
Our results have to be considered in the light of our present knowledge about: (a) the morphological differentiation of B cells in the embryonic chick pancreas along with the storage and secretion of insulin by this embryonic organ, (b) the biochemical and physiological characteristics of avian insulin, and (c) the tolerance of the host towards this embryonic endocrine transplant. A very sensitive immunohistological method allowed Dieterlen-Lievre and Beaupain (36) to demonstrate that in 13-to 17-d-old chick embryos numerous large insulin-containing islets were present in the splenic lobe of the pancreas. Their observations corroborate our quantitative evaluation of the insulin content of the splenic lobe of the pancreas between 12 and 20 d of incubation (29) . Benzo and Green (37) reported that a steady state of insulin concentration was reached between the 14th and 18th d ofincubation.
Little is known about the insulin-releasing ability of the chick embryonic pancreas but the plasma insulin concentration has been reported to increase between 11 and 16 d of incubation, to remain steady through day 20 and to decrease markedly at hatching (37) .
Chicken insulin is as active as crystalline beef, sheep, aind pork insulin when tested in vitro in the rat diaphragm bioassay (38) . These results indicate that the mammalian tissue receptor sites do not discriminate between these insulins which may vary in their amino acid sequences by at least six residues (39) . Insulin release during perfusion of the whole pancreas (40) , as well as during incubation of pancreatic pieces (41) release threshold for glucose observed in vitro helps to explain the high plasma glucose levels (200-250 mg/100 ml) found in birds (40) .
Nothing is known about the physiological regulation of insulin secretion in the chick embryo. Nevertheless, our results suggest that the embryonic transplants respond to high plasma glucose concentrations. The question arises whether this embryonic tissue can respond to lower levels of glucose because the fed blood sugar did not usually fall below 2.5 g/liter. Work is in progress to determine the threshold glucose concentration necessary to stimulate insulin release from a chick embryonic pancreas because the plasma glucose level of the embryo is below that of the adult I grafts such as the Krebs ascites tumor cells of mice (51) and lymphoid and bone marrow tissues of pigeons (52) . However by the 18th d of incubation, allogeneic cells were rejected, indicating that the fate of grafted cells differed in 14-and 18-d embryo hosts (53) .
What happens at this developmental stage? In the chick embryo hemopoietic stem cells first develop in the blood islands of the yolk sac. At a later stage stem cells leave the yolk sac and migrate into the primordia of other hemopoietic tissues (54) . They appear in the bursa of Fabricius on the 14th-15th d of incubation (55) . However, Ewald et al. (56) found only 9 .3% of rosette forming lymphocytes in the bursa of 15-d-old embryos and none in the spleen, bone marrow, or thymus. Potworowski (57) reported that 5% of bursal lymphocytes of the 14-d-old embryo expressed B antigen and not until after hatching did such lymphocytes occur in significant number in other lymphoid tissues. Seto (58) interpreted the low humoral immune competence of neonatal chicks to an inadequate level of T cells as well as to a small pool of B cells.
Because the induction of T-regulatory cells for suppression or cytotoxicity depends on antigen-dose and on activity of the cells they regulate (59) , it is conceivable that pancreatic tissue ofthe 15-d-old embryo is immunologically immature, lacking one or several lymphocyte subsets implicated in the afferent loop of the immune reaction. These components however may be present in an 18-d-old transplant. A more precise characterization of the immune modifications of the transplant between these two developmental stages will be the next step of our investigations.
